Quiz-summary
0 of 1 questions completed
Questions:
- 1
Information
Presented by Ralph Hruban, M.D. and prepared by Robert E LeBlanc, M.D.
Case 3: This patient underwent neoadjuvant therapy for a biopsy proven infiltrating adenocarcinoma.
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading...
You must sign in or sign up to start the quiz.
You have to finish following quiz, to start this quiz:
Results
Time has elapsed
Categories
- Not categorized 0%
- 1
- Answered
- Review
-
Question 1 of 1
1. Question
Week 530: Case 3
This patient underwent neoadjuvant therapy for a biopsy proven infiltrating adenocarcinoma.images/RHH7 01.jpg
images/RHH7 02.jpg
images/RHH7 03.jpg
images/RHH7 04.jpgCorrect
Answer: Almost complete response
Histology: This pancreas is remarkable for pools and pools of acellular mucin. The mucin not only involves the stroma of the pancreas, but is also present in the muscularis propia of the duodenum and in lymph nodes. Very rare atypical cells are present in the stroma.
Discussion: The differential diagnosis for stromal mucin in patients who haven’t been treated included mucin extruded from an intraductal papillary mucinous neoplasm (IPMN) and an invasive colloid carcinoma. The latter diagnosed by neoplastic epithelial cells floating in the stromal mucin, or neoplastic epithelial cells lining the pools of mucin in an abnormal location (such as in a nerve). In the present case, the patient received neoadjuvant therapy. The possibility that the stromal mucin represents mucin left behind by cancer that responded to treatment is supported by the abnormal location of the mucin (including in lymph nodes) and the rare residual atypical cells.
Incorrect
Answer: Almost complete response
Histology: This pancreas is remarkable for pools and pools of acellular mucin. The mucin not only involves the stroma of the pancreas, but is also present in the muscularis propia of the duodenum and in lymph nodes. Very rare atypical cells are present in the stroma.
Discussion: The differential diagnosis for stromal mucin in patients who haven’t been treated included mucin extruded from an intraductal papillary mucinous neoplasm (IPMN) and an invasive colloid carcinoma. The latter diagnosed by neoplastic epithelial cells floating in the stromal mucin, or neoplastic epithelial cells lining the pools of mucin in an abnormal location (such as in a nerve). In the present case, the patient received neoadjuvant therapy. The possibility that the stromal mucin represents mucin left behind by cancer that responded to treatment is supported by the abnormal location of the mucin (including in lymph nodes) and the rare residual atypical cells.